The Latest Cardiac and Vascular News
Study evaluates therapy optimization and system management of endovascular pulmonary neuromodulation in ADHF MINNEAPOLIS, May 19, 2022 /PRNewswire/ — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial enrollment in their STIM-ADHF Study. The study will evaluate therapy optimization and system management of the Cardiac Pulmonary Nerve Stimulation (CPNS™) System in […]
MINNEAPOLIS, May 19, 2022 /PRNewswire/ — 4C Medical Technologies, Inc. (“4C Medical” or the “Company”), a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease, presented its global clinical experience from its initial AltaValve Early Feasibility Study (EFS) cases at the American Association for Thoracic Surgery (AATS) […]
Data presented at EuroPCR 2022 reinforce the impact of Abbott’s minimally invasive heart devices on patient outcomes and quality of life Findings demonstrate TriClip™ transcatheter edge-to-edge (TEER) repair is effective at reducing tricuspid regurgitation across a broad range of anatomies One-year outcomes for Navitor™ transcatheter aortic valve implantation (TAVI) system […]
XyloCor Therapeutics Announces Presentation of Preliminary Clinical Data from Phase 1 Portion of the EXACT Phase 1/2 Study of XC001 Novel Gene Therapy for Refractory Angina at AATS and ASGCT – Data from the Phase 1 dose-escalation portion of the Phase 1/2 EXACT study demonstrate XC001 was well-tolerated at all dose […]
Northwell Health has joined the Cardiometabolic Center Alliance (CMCA) as a charter member, which was founded by Saint Luke’s Mid America Heart Institute in St. Louis, to provide innovative treatment approaches to patients with type 2 diabetes and cardiovascular disease. As a charter member, Northwell will further its ongoing research […]
Results presented at EuroPCR 2022 show notable reduction of blood pressure in patients on and off medications at six months PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”) and Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) a fully owned subsidiary of Otsuka Holdings Co., Ltd., today announced that Dr. Ajay […]
Medtronic adds to SPYRAL HTN Global Clinical Program with late breaking clinical data for SPYRAL HTN-ON MED and GSR-DEFINE DUBLIN and PARIS, May 17, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced data showing the benefits of the Symplicity Blood Pressure Procedure with the Symplicity Spyral™ Renal Denervation […]
The heart failure program is a new model for cardiology practices in managing heart failure, starting with patients in Northeast Florida NEW YORK, May 17, 2022 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care platform, has launched an innovative heart failure program that combines individualized health coaching and remote patient monitoring to improve […]
LITTLE ROCK, Ark., May 17, 2022 /PRNewswire/ — HealthTech Arkansas and MedAxiom have come together to create HeartX, a cardiovascular-focused healthcare accelerator, to facilitate guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market. Applications for the 2022 HeartX cohort are now open, and companies […]
ROCKVILLE, Md. , May 17, 2022 /PRNewswire/ — A new position paper published today by the Heart Failure Society of America (HFSA) outlines disparities in healthcare that affect patients with heart failure, including race and ethnicity, socioeconomic factors, and social determinants of health. The statement also presents actions that can be taken to […]
